UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000050468
Receipt number R000057478
Scientific Title Evaluation of blood concentration of oxytocin in hypertonic saline test
Date of disclosure of the study information 2023/04/01
Last modified on 2023/09/01 10:52:16

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of blood concentration of oxytocin in hypertonic saline test

Acronym

Evaluation of blood concentration of oxytocin in hypertonic saline test

Scientific Title

Evaluation of blood concentration of oxytocin in hypertonic saline test

Scientific Title:Acronym

Evaluation of blood concentration of oxytocin in hypertonic saline test

Region

Japan


Condition

Condition

Central diabetes insipidus, diencephalohypophysial diseases

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Changes in blood concentration of oxytocin in hypertonic saline test in patients with diencephalohypophysial diseases (without central diabetes insipidus)

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Changes in blood concentration of oxytocin in hypertonic saline test in patients with diencephalohypophysial diseases (without central diabetes insipidus)

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Device,equipment

Interventions/Control_1

Hypertonic saline infusion test

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients suspected to have central diabetes insipidus or diencephalohypophyseal diseases

Key exclusion criteria

Patients with hypernatremia (serum sodium concentration higher than or equal to 150 mEq/L)

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Hiroshi
Middle name
Last name Arima

Organization

Nagoya University Graduate School of Medicine

Division name

Department of Endocrinology and Diabetes

Zip code

466-8550

Address

65 Tsurumai-cho, Showa-ku, Nagoya, Aichi, Japan

TEL

052-744-2142

Email

arima105@med.nagoya-u.ac.jp


Public contact

Name of contact person

1st name Daisuke
Middle name
Last name Hagiwara

Organization

Nagoya University Graduate School of Medicine

Division name

Department of Endocrinology and Diabetes

Zip code

466-8550

Address

65 Tsurumai-cho, Showa-ku, Nagoya, Aichi, Japan

TEL

052-744-2142

Homepage URL


Email

d-hagiwarai@med.nagoya-u.ac.jp


Sponsor or person

Institute

Nagoya University

Institute

Department

Personal name



Funding Source

Organization

YAMASA CORPORATION

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nagoya University Graduate School of Medicine

Address

65 Tsurumai-cho, Showa-ku, Nagoya, Aichi, Japan

Tel

052-744-2973

Email

ethics@med.nagoya-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 04 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2023 Year 04 Month 01 Day

Date of IRB

2023 Year 05 Month 17 Day

Anticipated trial start date

2023 Year 05 Month 30 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 03 Month 02 Day

Last modified on

2023 Year 09 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000057478


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name